Continuing Medical Education Coalition

Spending by Year

Lobbying Firms

What They Lobby For

• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS.
• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; SUPPORT for Patients and Communities Act (H.R.6); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).
• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; SUPPORT for Patients and Communities Act (H.R.6/P.L.115-271); Opioid Prevention and Treatment Act of 2017 (H.R.993); Improve Addiction Education Act (H.R.4075); ADAPT Act (H.R.5581); REACH OUT Act (H.R.5796).
• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8).
• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars.
• Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars.
• Issues related to the promotion of continuing medical education (CME) and the pandemic. H.R. 748 and S. 3548, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act. Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars.
• Issues related to the promotion of continuing medical education (CME) and the pandemic. The Cares Act, Public Law 116-136. Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars. H.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act. Senate COVID-19 response legislation.
• Issues related to the promotion of continuing medical education (CME) and the pandemic. The Cares Act (P.L. 116-136). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars. H.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act. Senate COVID-19 response legislation.
• Issues related to the promotion of continuing medical education (CME) and the pandemic. H.R.7614, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2021. HR 133, Consolidating Appropriations Act, 2021.

Related Investigations

Explore More